aTyr Pharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.9% | -30.9% | -29.2% |
| FY2022 | -63.4% | -63.4% | -47.3% |
| FY2023 | -55.6% | -55.6% | -41.8% |
| FY2024 | -91.4% | -91.4% | -66.1% |
| FY2025 | -109.8% | -109.8% | -79.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.9% | -30.9% | -29.2% |
| FY2022 | -63.4% | -63.4% | -47.3% |
| FY2023 | -55.6% | -55.6% | -41.8% |
| FY2024 | -91.4% | -91.4% | -66.1% |
| FY2025 | -109.8% | -109.8% | -79.7% |